RecruitingPhase 2NCT04760327

Electrochemotherapy of Gynecological Cancers

Sponsor

Institute of Oncology Ljubljana

Enrollment

30 participants

Start Date

Jul 1, 2020

Study Type

INTERVENTIONAL

Conditions

Gynecological Cancers

Summary

To determine the effectiveness, feasibility and safety of electrochemotherapy in treatment of local and/or regional recurrences of gynecological cancers with electrochemotherapy in which standard treatment options have been exhausted.

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 105 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Electrochemotherapy with bleomycin or cisplatin for people with gynecological cancers. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 105 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

COMBINATION_PRODUCTElectrochemotherapy with bleomycin or cisplatin

Electrochemotherapy with cisplatin or bleomycin of gynecological cancers

Locations(1)

Institute of oncology Ljubljna

Ljubljana, Slovenia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04760327

Related Trials

Emotional Assessment and Tiered Individualized Psychological Support of the Artificial Intelligence Robot

NCT073657611 location

Study to Assess the Safety and Effects of Porphysome Nanoparticles for Imaging in Gynaecological Cancers

NCT069771261 location

Anxiety, Physiological Parameters, Patient Satisfaction and VR in Gynecological Oncology Surgery

NCT070168801 location

Gene and Molecular Pathways of Ozone Treatment Response in Gynecological Tumor Patients With Chronic Pelvic Pain Secondary to Cancer Treatment

NCT068160951 location